转移潜力:原发性瘤的一般性倾向或罕见的转移变异 - - 或两者兼而有之?
1Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. rohynes@mit.edu
Cell
|July 3, 2003
概括
转移,癌症的扩散,可能源于罕见的,攻击性的细胞或随机从瘤中产生. 新兴的模型表明,这两种机制的结合推动了癌症的传播.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 遗传学 是一个遗传学.
背景情况:
- 转移是癌症患者生存的关键决定因素.
- 转移的细胞起源仍然不完全理解.
- 存在两个主要假设:罕见的,高度转移的细胞与从前发病状态的随机事件.
研究的目的:
- 审查和综合目前关于转移机制的证据.
- 评估竞争中的转移性发病模式.
- 提出综合模型,调和现有假设.
主要方法:
- 文献综述和现有研究的综合.
- 分析支持不同转移模型的论据.
- 讨论癌症细胞生物学最近的发现.
主要成果:
- 证据支持转移的罕见细胞和随机模型.
- 最近在"癌细胞"杂志上发表的一篇文章表明,综合模型更为可信.
- 这些综合模型包含了细胞进化和随机进展的元素.
结论:
- 转移很可能是由复杂的因素相互作用引起的,而不是单一的机制.
- 未来的研究应该专注于了解这些联合机制如何促进癌症进展.
- 综合模型为研究和潜在的向转移提供了更全面的框架.
相关概念视频
Overview of Transposition and Recombination
Transposons make up a significant part of genomes of various organisms. Therefore, it is believed that transposition played a major evolutionary role in speciation by changing genome sizes and modifying gene expression patterns. For example, in bacteria, transposition can lead to conferring antibiotic resistance. Movement of transposable elements within the genetic pool of pathogenic bacteria can aid in transfer of antibiotic-resistant genetic elements. In eukaryotes, transposons can carry out...
Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...


